Clinical trial

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

NCT03314805

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-03-01

PhasePHASE2

Study timeline

Study start (actual)2018-03-01Date precision: day

Registry last updated2026-06-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancer-related Fatigueunresolved

Neutropenia, Malignantunresolved

Interventions

Astragalus polysaccharides 500 mgDRUG

PlaceboDRUG

EC ChemotherapyPROCEDURE

Sponsors & collaborators

PhytoHealth Corporationlead sponsor

Mapped research locations

Kaohsiung CityTaiwan2 TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03314805 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.